These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32933390)

  • 41. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    Elbey MA; Cil H; Onturk E; Islamoglu Y
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arrhythmic storm: Short-coupled variant torsade de pointes.
    Godinho AR; Frutuoso C; Vasconcelos M; Dias P; Garcia R; Pinho T; Araújo V; Maciel MJ
    Rev Port Cardiol; 2016 May; 35(5):307.e1-5. PubMed ID: 27132471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Torsade de pointes in initiating hemodialysis: a case report.
    Yang JA; Choi HS; Bae EH; Ma SK; Kim SW; Kim CS
    Ann Palliat Med; 2020 May; 9(3):1264-1268. PubMed ID: 32389016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ibutilide-induced long QT syndrome and torsade de pointes.
    Gowda RM; Punukollu G; Khan IA; Patlola RR; Tejani FH; Cosme-Thormann BF; Vasavada BC; Sacchi TJ
    Am J Ther; 2002; 9(6):527-9. PubMed ID: 12424513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acquired long QT syndrome with torsade de pointes in a patient with primary hypothyroidism].
    Kukla P; Szczuka K; Słowiak-Lewińska T; Bromblik A; Hajduk B; Kluczewski M; Lenard B; Przewor M
    Kardiol Pol; 2003 Mar; 58(3):224-6. PubMed ID: 14513098
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Torsade de pointes].
    Haverkamp W; Hördt M; Chen X; Hindricks G; Willems S; Kottkamp H; Rotman B; Brunn J; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Dec; 82(12):763-74. PubMed ID: 8147050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
    Havakuk O; Viskin S
    J Am Coll Cardiol; 2016 Jun; 67(23):2806-2807. PubMed ID: 27282904
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical observation on pause-dependent long QT syndrome and torsade de pointes ventricular tachycardia].
    Song YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Dec; 20(6):349-51, 389. PubMed ID: 1307971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proarrhythmic effects of the class III agent almokalant: importance of infusion rate, QT dispersion, and early afterdepolarisations.
    Carlsson L; Abrahamsson C; Andersson B; Duker G; Schiller-Linhardt G
    Cardiovasc Res; 1993 Dec; 27(12):2186-93. PubMed ID: 8313427
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Torsade de pointes and T-wave alternans in a patient with brainstem hemorrhage.
    Chao CL; Chen WJ; Wu CC; Lee YT
    Int J Cardiol; 1995 Sep; 51(2):199-201. PubMed ID: 8522417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. QT prolongation and torsade de pointes ventricular tachycardia produced by Ketanserin.
    Aldariz AE; Romero H; Baroni M; Baglivo H; Esper RJ
    Pacing Clin Electrophysiol; 1986 Nov; 9(6):836-41. PubMed ID: 2432486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.
    Gintant GA; Limberis JT; McDermott JS; Wegner CD; Cox BF
    J Cardiovasc Pharmacol; 2001 May; 37(5):607-18. PubMed ID: 11336111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological mechanism of the characteristic electrocardiographic morphology of torsade de pointes tachyarrhythmias in the long-QT syndrome: detailed analysis of ventricular tridimensional activation patterns.
    El-Sherif N; Chinushi M; Caref EB; Restivo M
    Circulation; 1997 Dec; 96(12):4392-9. PubMed ID: 9416909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mode of onset of torsade de pointes in congenital long QT syndrome.
    Viskin S; Alla SR; Barron HV; Heller K; Saxon L; Kitzis I; Hare GF; Wong MJ; Lesh MD; Scheinman MM
    J Am Coll Cardiol; 1996 Nov; 28(5):1262-8. PubMed ID: 8890825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular mechanisms underlying the long QT syndrome.
    Antzelevitch C; Shimizu W
    Curr Opin Cardiol; 2002 Jan; 17(1):43-51. PubMed ID: 11790933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm.
    Viskin S; Fish R; Roth A; Copperman Y
    Heart; 1998 Apr; 79(4):417-9. PubMed ID: 9616356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ciprofloxacin- and hypocalcemia-induced torsade de pointes triggered by hemodialysis.
    Daya SK; Gowda RM; Khan IA
    Am J Ther; 2004; 11(1):77-9. PubMed ID: 14704599
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunosuppressant associated torsades de pointes after acute heart rejection in an 8-year-old boy.
    Hsin-Ming L; Wei-Chieh T; Shuenn-Nan C
    Cardiol Young; 2020 Aug; 30(8):1194-1195. PubMed ID: 32602425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.